Cargando…

Combretastatin-Inspired Heterocycles as Antitubulin Anticancer Agents

[Image: see text] Combretastatin (CA-4) and its analogues are undergoing several clinical trials for treating different types of tumors. In this work, the antiproliferative activity of a series of 2-aminoimidazole-carbonyl analogs of clinically relevant combretastatins A-4 (CA-4) and A-1 was evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hura, Neha, Sawant, Avishkar V., Kumari, Anuradha, Guchhait, Sankar K., Panda, Dulal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2018
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644768/ https://www.ncbi.nlm.nih.gov/pubmed/31459105 http://dx.doi.org/10.1021/acsomega.8b00996

Ejemplares similares

Drug-Clinical Agent Molecular Hybrid: Synthesis of Diaryl(trifluoromethyl)pyrazoles as Tubulin Targeting Anticancer Agents
por: Hura, Neha, et al.
Publicado: (2018)

An Antitubulin Agent BCFMT Inhibits Proliferation of Cancer Cells and Induces Cell Death by Inhibiting Microtubule Dynamics
por: Rai, Ankit, et al.
Publicado: (2012)

Copper-Plumbagin Complex Produces Potent Anticancer Effects by Depolymerizing Microtubules and Inducing Reactive Oxygen Species and DNA Damage
por: Mukherjee, Sandipan, et al.
Publicado: (2023)

Design, Synthesis and Antitumor Activity of Novel link-bridge and B-Ring Modified Combretastatin A-4 (CA-4) Analogues as Potent Antitubulin Agents
por: Duan, Yong-Tao, et al.
Publicado: (2016)

Synthesis and Cytotoxic Activity of a New Group of Heterocyclic Analogues of the Combretastatins
por: Lipeeva, Alla V., et al.
Publicado: (2014)

Development of Combretastatin A-4 Analogues as Potential Anticancer Agents with Improved Aqueous Solubility
por: Chen, Zhi-Hao, et al.
Publicado: (2023)

Design, Synthesis, and Biological Evaluation of Novel Pyridine-Bridged Analogues of Combretastatin-A4 as Anticancer Agents
por: Zheng, Shilong, et al.
Publicado: (2014)

Pharmacokinetic Profile Evaluation of Novel Combretastatin Derivative, LASSBio-1920, as a Promising Colorectal Anticancer Agent
por: Guimarães, Celina de Jesus, et al.
Publicado: (2023)

Identification of Potential Antitubulin Agents with Anticancer Assets from a Series of Imidazo[1,2-a]quinoxaline Derivatives: In Silico and In Vitro Approaches
por: Goel, Kapil Kumar, et al.
Publicado: (2023)

Potent Anticancer Activity with High Selectivity of a Chiral Palladium N-Heterocyclic Carbene Complex
por: Kumar, Anuj, et al.
Publicado: (2017)

CuI-mediated synthesis of 1-aryl-5,6,7-trimethoxybenzimidazoles as potent antitubulin agents
por: Peng, Cong-Min, et al.
Publicado: (2023)

Combretastatin A4-camptothecin micelles as combination therapy for effective anticancer activity
por: Assali, Mohyeddin, et al.
Publicado: (2019)

New Heterocyclic Combretastatin A-4 Analogs: Synthesis and Biological Activity of Styryl-2(3H)-benzothiazolones
por: Atanasov, Gjorgji, et al.
Publicado: (2021)

The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation
por: Porcù, Elena, et al.
Publicado: (2016)

Correction: CuI-mediated synthesis of 1-aryl-5,6,7-trimethoxybenzimidazoles as potent antitubulin agents
por: Peng, Cong-Min, et al.
Publicado: (2023)

Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4
por: Malebari, Azizah M., et al.
Publicado: (2021)

A Screen for Kinetochore-Microtubule Interaction Inhibitors Identifies Novel Antitubulin Compounds
por: Screpanti, Emanuela, et al.
Publicado: (2010)

Genetic screening reveals a link between Wnt signaling and antitubulin drugs
por: Khan, A H, et al.
Publicado: (2016)

Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling
por: Zhao, Yulei, et al.
Publicado: (2015)

Natural Alkaloids and Heterocycles as G-Quadruplex Ligands and Potential Anticancer Agents
por: Che, Tong, et al.
Publicado: (2018)

In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents
por: Tahlan, Sumit, et al.
Publicado: (2019)

New Quinoline-Based Heterocycles as Anticancer Agents Targeting Bcl-2
por: Hamdy, Rania, et al.
Publicado: (2019)

In vitro Mechanistic Exploration of Novel Spiropyrrolidine Heterocyclic Hybrids as Anticancer Agents
por: Kumar, Raju Suresh, et al.
Publicado: (2020)

Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
por: Kumar, Adarsh, et al.
Publicado: (2023)

Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents
por: Romagnoli, Romeo, et al.
Publicado: (2017)

Small Heterocyclic Ligands as Anticancer Agents: QSAR with a Model G-Quadruplex
por: Kaneti, Jose, et al.
Publicado: (2022)

Rat monoclonal antitubulin antibodies derived by using a new nonsecreting rat cell line
Publicado: (1982)

Cytotoxicity Studies of Novel Combretastatin and Pterostilbene Derivatives
por: Jakubowska, Joanna, et al.
Publicado: (2014)

Novel Selective Estrogen Receptor Ligand Conjugates Incorporating Endoxifen-Combretastatin and Cyclofenil-Combretastatin Hybrid Scaffolds: Synthesis and Biochemical Evaluation
por: Kelly, Patrick M., et al.
Publicado: (2017)

Design, synthesis and biological potential of heterocyclic benzoxazole scaffolds as promising antimicrobial and anticancer agents
por: Kakkar, Saloni, et al.
Publicado: (2018)

Synthesis and Reactions of Some New Heterocyclic Carbohydrazides and Related Compounds as Potential Anticancer Agents
por: Mansour, Abdel Kader, et al.
Publicado: (2003)

Novel Homo-Bivalent and Polyvalent Compounds Based on Ligustrazine and Heterocyclic Ring as Anticancer Agents
por: Wang, Jiawen, et al.
Publicado: (2019)

N-Heterocyclic Carbene Iron Complexes as Anticancer Agents: In Vitro and In Vivo Biological Studies
por: Lenis-Rojas, Oscar A., et al.
Publicado: (2021)

Synthesis, and docking studies of novel heterocycles incorporating the indazolylthiazole moiety as antimicrobial and anticancer agents
por: Dawoud, Nadia T. A., et al.
Publicado: (2022)

Electron microscope demonstration of tubulin in cilia and basal bodies of rat tracheal epithelium by the use of an antitubulin antibody
Publicado: (1977)

Exploring Diverse-Ring Analogues on Combretastatin A4 (CA-4) Olefin as Microtubule-Targeting Agents
por: Song, Ming-Yu, et al.
Publicado: (2020)

Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect
por: Ibrahim, Tarek S., et al.
Publicado: (2021)

Novel indole-bearing combretastatin analogues as tubulin polymerization inhibitors
por: Kumar, Sunil, et al.
Publicado: (2013)

Synthesis and Biological Evaluation of Some Novel Thiazole-Based Heterocycles as Potential Anticancer and Antimicrobial Agents
por: Abu-Melha, Sraa, et al.
Publicado: (2019)

Exploring Pyrrolo-Fused Heterocycles as Promising Anticancer Agents: An Integrated Synthetic, Biological, and Computational Approach
por: Amărandi, Roxana-Maria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u5guha2qprs489be42iccnis48